Related references
Note: Only part of the references are listed.Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids
Gary T. Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression
Xiaoyi Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest
Jing-Ruey J. Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties
M Kawai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: A structural basis for the reduction of albumin binding
George S. Sheppard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
MAP1D, a novel methionine aminopeptidase family member is overexpressed in colon cancer
M Leszczyniecka et al.
ONCOGENE (2006)
A novel methionine aminopeptidase-2 inhibitor, PPI-2458, inhibits non-Hodgkin's lymphoma cell proliferation in vitro and in vivo
AC Cooper et al.
CLINICAL CANCER RESEARCH (2006)
Methionine aminopeptidases type I and type II are essential to control cell proliferation
SG Bernier et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models
MJ Morowitz et al.
CLINICAL CANCER RESEARCH (2005)
Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese
JY Wang et al.
BIOCHEMISTRY (2003)
High expression of methionine aminopeptidase type 2 in germinal center B cells and their neoplastic counterparts
T Kanno et al.
LABORATORY INVESTIGATION (2002)
The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest
JRJ Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Structure and function of the methionine aminopeptidases
WT Lowther et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
MAPs and POEP of the roads from prokaryotic to eukaryotic kingdoms
B Datta
BIOCHIMIE (2000)
Share Paper
